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Translocation of Src Kinase to the Cell Periphery 
Is Mediated by the Actin Cytoskeleton under 
the Control of the Rho Family of Small G Proteins 
V.J. Fincham, M. Unlu, V.G. Brunton, J.D. Pitts, J.A. Wyke, and M.C. Frame 
The Beatson Institute for Cancer Research, CRC Beatson Laboratories, Glasgow, Scotland G61 1BD 
Abstract. We have isolated Swiss 3T3 subclones that 
are resistant to the rnitogenic and morphological trans- 
forming effects of v-Src as a consequence of aberrant 
translocation of the oncoprotein under low serum con- 
ditions. In chicken embryo and NIH 3T3 fibroblasts un- 
der similar conditions, v-Src rapidly translocates from 
the perinuclear region to the focal adhesions upon acti- 
vation of the tyrosine kinase, resulting in downstream 
activation of activator protein-1 and mitogen-activated 
protein kinase, which are required for the mitogenic 
and transforming activity of the oncoprotein. Since se- 
rum deprivation i duces cytoskeletal disorganization in 
Swiss 3T3, we examined whether egulators of the cy- 
toskeleton play a role in the translocation of v-Src, 
and also c-Src, in response to biological stimuli. Actin 
stress fibers and translocation of active v-Src to focal 
adhesions in quiescent Swiss 3T3 cells were restored by 
microinjection of activated Rho A and by serum. Dou- 
ble labeling with anti-Src and phalloidin demonstrated 
that v-Src localized along the reformed actin filaments 
in a pattern that would be consistent with trafficking in 
complexes along the stress fibers to focal adhesions. 
Furthermore, treatment with the actin-disrupting drug 
cytochalasin D, but not the microtubule-disrupting 
drug nocodazole, prevented v-Src translocation. In ad- 
dition to v-Src, we observed that PDGF-induced, Rac- 
mediated membrane ruffling was accompanied by 
translocation of c-Src from the cytoplasm to the plasma 
membrane, an effect hat was also blocked by cytocha- 
lasin D. Thus, we conclude that translocation of Src 
from its site of synthesis to its site of action at the cell 
membrane requires an intact cytoskeletal network and 
that the small G proteins of the Rho family may specify 
the peripheral localization in focal adhesions or along 
the membrane, mediated by their effects on the cyto- 
skeleton. 
T 
HE product of the v-src gene is a protein tyrosine ki- 
nase that, in its active form, localizes to the plasma 
membrane where it initiates a cascade of signaling 
events leading to altered cell growth and behavior. We, 
and others, have extensively studied the GdG1- to S-phase 
progression induced by v-Src in rat and chicken embryo 
cells withdrawn from the cell cycle by serum deprivation 
(Bell et al., 1975; Durkin and Whitfield, 1984; Welham et al., 
1990; Catling et al., 1993; Wyke et al., 1993). Over the past 
few years, some of the intracellular signals that are crucial 
for the mitogenic activity of the v-Src oncoprotein have 
been identified. These include the signaling pathway that 
links p21 Ras to the mitogen-activated protein (MAP) 1 ki- 
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nases and their targets (Gupta et al., 1992; Howe et al., 
1992; Wang and Erickson, 1992; Cowley et al., 1994; Wyke 
et al., 1995) and the transcription factor AP-1, which is ac- 
tivated by a variety of mechanisms in different cell types 
(Welham et al., 1990; Catling et al., 1993). In addition, we 
have demonstrated that activation of MAP kinase and ac- 
tivator protein-1 (AP-1) occur at times during G1 when 
v-Src activity is required and that both are necessary for 
mitogenesis (Frame et al., 1994; Wyke et al., 1995). We 
have also shown that the ability of v-Src to morphologi- 
cally transform fibroblasts is not impaired by attenuation 
of either MAP kinase or AP-1 activation, indicating that 
the pathways that regulate mitogenesis are biochemically 
distinct from those that induce cell shape changes (Frame 
et al., 1994; Wyke et al., 1995). However, both the mito- 
genic and morphological effects of v-Src require its local- 
ization at the cell membrane (Catling et al., 1993). 
Despite our increasing understanding of the role of the 
Ras/MAP kinase pathway and AP-1 in the mitogenic ac- 
tivity of v-Src, there is still no clear information on the up- 
stream events that initiate this process. Our studies to date 
have used Rat-1 or chicken embryo fibroblasts expressing 
a temperature-sensitive mutant of v-Src (ts LA29), in 
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which a single point mutation in the kinase domain gives 
rise to both temperature-dependent ki ase activity and 
temperature-dependent localization to the cell periphery 
(Welham and Wyke, 1988). In this study, we describe 
Swiss 3T3 cell clones that are resistant to the mitogenic ef- 
fects of ts LA29 v-Src upon shifting serum-deprived cells 
to the permissive temperature and describe characteriza- 
tion of the defect hat is responsible for the lack of v-Src- 
induced MAP kinase and AP-1 activation and their bio- 
logical consequences. For comparison, we used ts LA29 
v-Src-expressing NIH 3T3 cells that undergo G 0- to S-phase 
transition in response to shift to permissive temperature. 
We demonstrate hat cytoskeletal disruption, which occurs 
in Swiss 3T3 cells that have been deprived of serum (Rid- 
Icy and Hall, 1992), is associated with their resistance to 
v-Src-induced mitogenesis as a consequence of impaired 
translocation of ts LA29 v-Src to the cell periphery. We 
further show that serum-induced reformation of the orga- 
nized actin cytoskeletal network restores v-Src transloca- 
tion upon shift to permissive temperature. These observa- 
tions led us also to examine the subcellular localization of 
c-Src in response to a biological stimulus known to require 
c-Src activity and to conclude that the cytoskeleton also 
plays a crucial role in the redistribution of c-Src from the 
perinuclear cytoplasm to its membrane sites of action. We 
provide evidence that stimulus-specific cytoskeletal rear- 
rangements, which are known to be mediated by members 
of the Rho family of small G proteins, may specify the lo- 
calization of Src kinases at the plasma membrane. 
Materials and Methods 
Generation of Cell Lines 
Swiss 3T3 and NIH 3T3 cell lines grown in DME supplemented with 10% 
FCS were transfected with 1 ~g of the Moloney murine leukaemia virus 
based vector fpGV-1 (DeClue and Martin, 1989), into which the coding 
sequences for ts LA29 v-src had been cloned (provided to us by Andy 
Catling, The Beatson Institute). Transfections were by the DOTAP 
method (Boehringer Mannheim Corp., Indianapolis, IN) as per manufac- 
turer's instructions, and neomycin-resistant colonies were selected in 
G418 (GIBCO BRL) at 500 ixg/ml. Single colonies were isolated and 
those shown to express high levels of v-Src by immunoblotting (see Fig. 
1) were chosen for study. CEF/R29 used for comparison i v-Src localiza- 
tion studies were generated by transfection of the replication competent 
Rous-associated virus encoding ts LA29 v-src as described previously 
(Catling et al., 1994). Cytochalasin D (Sigma Chemical Co., St. Louis, MO) 
was dissolved in DMSO and added to the culture medium to a final con- 
centration of 0.1 p.g/ml. Nocodazole (Sigma Chemical Co.) was dissolved 
in DMSO and used at 0.5 ixg/ml. 
Immunoblotting and Src Kinase Assays 
v-Src was detected by preparing lysates in 0.1 M Tris, pH 8, 2% SDS and 
1 mM DTT, which were separated on a 10% SDS-PAGE, blotted onto 
nitrocellulose, blocked with 5% milk, and probed with mAb ECIO (Up- 
state Biotechnology, Inc., Lake Placid, NY) specific for avian Src. Detec- 
tion was by reaction with sheep anti-mouse IgG conjugated to horse- 
radish peroxidase and ECL (Amersham Corp., Arlington Heights, IL). 
Immune-complex kinase assays were carried out as follows. Cultures were 
lysed in NP-40 buffer (20 mM Tris, pH 6.8, 150 mM sodium chloride, 1% 
NP-40, 20 mM sodium pyrophosphate, 10 i.tM sodium orthovanadate, 2 I.LM 
PMSF, 1 p~g/ml aprotinin) for 20 min on ice. Lysates were clarified by 
high-speed spin at 4°C and precleared with normal rabbit serum and pro- 
tein A-Sepharose (Sigma Chemical Co.). v-Src from 50 Izg lysate was 
reacted with mAb EC10 (Upstate Biotechnology, Inc.) and collected on 
rabbit anti-mouse-coated protein A-Sepharose. Immunoprecipitates 
were washed in NP-40 buffer and kinase assay buffer (1130 mM Pipes-sodium, 
pH 6.8, 20 mM manganese chloride, 10 p.M sodium orthovanadate) before 
resuspending in kinase assay buffer. An aliquot of v-Src-protein A--Sepha- 
rose (amount checked so that assay conditions were linear) was incubated 
with 5 p.Ci of [~-32p]ATP (3,000 Ci/mM) (Amersham Corp.) and 1 ~g de- 
natured enolase in a final assay volume of 20 I~1. The reaction was stopped 
by addition of 20 p,l 0.1 M Tris, pH 8, 2% SDS, and 1 mM DTT, and the 
supernatant was separated by 10% SDS-PAGE. Lysate protein concen- 
trations for immune-complex kinase assays and AP-1 DNA-binding as- 
says were determined using the Micro BCA Protein Assay Kit (Pierce, 
Rockford, IL). 
Mitogenesis 
Cells were made quiescent by transferring to medium containing 0.4% 
newborn calf serum and maintained at the restrictive temperature (40°C) 
for 24--48 h. Stimulation was by shift to the permissive t mperature (35°C) 
or addition of 10% serum. DNA synthesis was measured by pulse labeling 
with tritiated methylthymidine (Amersham Corp.) as described previously 
(Welham et al., 1990). 
AP-1 DNA--binding and MAP Kinase Assays 
Cells from 100-mm dishes were lysed in 100 ~1 of buffer containing 20 mM 
Hepes, pH 7.9, 5 mM EDTA, 10 mM EGTA, 5 mM sodium fluoride, 0.1 
p.g/ml okadaic acid, 1 mM DTT, 0.4 M potassium chloride, 0.4% Triton 
X-100, 10% glycerol, and a mixture of protease inhibitors including pep- 
statin A, leupeptin, and aprotinin (all at 5 p,g/ml), together with 1 mM 
benzamidine and 0.25 mM PMSF. Lysates were clarified by high-speed 
spin at 4°C. DNA-binding reactions were carried out in 20 mM Hepes 
buffer, pH 7.9, with 50 mM sodium chloride, 5 mM magnesium chloride, 
and 3 ~g poly-dldC. An oligonucleotide probe representing the collage- 
nase AP-1 site (AGCTGTGTCTGACTCATGCT) was end labeled using 
[~/-32p]ATP and T4 polynucleotide kinase (Northumberland Biologicats) 
and incubated with 15 p,g protein for 30 min on ice. DNA-protein com- 
plexes were resolved by electrophoresis in 4% polyacrylamide g ls. 
The activity of p42 MAP kinase (ERK2) in 50 p.g cell lysate was mea- 
sured by immune-complex kinase assays using an antiserum raised against 
the carboxy-terminal peptide of ERK2 as was used by Leevers and Mar- 
shall (1992), exactly as described in Wyke et al. (1995). 
Immunofluorescence 
For immunofluorescence confocal microscopy, cells were grown on glass 
coverslips, fixed at 4°C for 15 min with 3.7% formaldehyde, and perme- 
abilized with 0.5% Triton X-100 before incubation with 1:1,000 anti-Src 
mAb EC10, 1:100 antivinculin (Sigma Chemical Co.), 1:5 anti-Src mAb 
N2-17 (gift from Tony Hunter, Salk Institute, San Diego, CA), 1:500 anfitu- 
bulin (Sigma Chemical Co.), or 1 ng/ml TRITC-conjugated phalloidin 
(Sigma Chemical Co.) for 60 min at room temperature. Antibody detec- 
tion was by reaction with FITC-conjugated goat anti-mouse tgG (Sigma 
Chemical Co.) for 45 rain at room temperature. As control, cells were in- 
cubated with conjugated second antibody alone. The cells were visualized 
using a confocal microscope (model MRC600; BioRad Labs, Hercules, 
CA). Images were printed on a dye sublimation printer (Eastman Kodak, 
Rochester, NY). 
Microinjection of Rho A 
pGEX-2T-rho A was kindly provided to us by Alan Hall (University Col- 
lege, London, UK). We derived Val 14-rho A by PCR-based mutagenesis. 
GST-Val 14-Rho A protein was prepared, cleaved by thrombin (Sigma 
Chemical Co.) and purified as described for Rac proteins (Ridley et al., 
1992). Protein preparations were checked for activity by the method of 
Hall and Self (1986). Val 14-Rho A protein (1 p.g/ml) in 50 mM Tris, pH 
7.5, 50 mM NaC1, 5 mM Mg C12, and 0.01 mM DTT was mixed with fil- 
tered Lucifer yellow CH dye (2%) and injected into about 40 quiescent 
Swiss 3T3-f29 cells per experiment using a microiujector system (model 
5254; Eppendorf, Inc., Fremont, CA). After microinjection, cells were in- 
cubated in low serum medium at 40°C for several hours before switching 
to 35°C. Swiss 3T3-f29 cells are not coupled by GAP junctions, and Luci- 
fer yellow provided a marker of injected cells. As controls, we examined 
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cells microinjected with dye alone and cells microinjected with Val 14-
Rho A maintained at the restrictive temperature. 
Results 
Swiss 3T3 Cells Are  Resistant o 
v-Src- induced Mitogenesis 
Initial characterization of several independent clones of 
Swiss 3T3, which stably express high levels of ts LA29 v-Src, 
demonstrated that the oncoprotein was unable to induce a 
mitogenic response in Swiss 3T3 cells that had been made 
quiescent by serum deprivation. This was shown by the 
lack of stimulation of thymidine uptake after shift to the 
permissive temperature (35°C) (Fig. 1 a) and was in con- 
trast to fibroblasts from other species, including rat and 
chicken (Welham et al., 1990; Catling et al., 1993). v-Src 
was also able to act as a mitogen in quiescent NIH 3T3 
cells expressing similar amounts of ts LA29 v-Src (Fig. 1 b), 
showing that the lack of response in Swiss 3T3 was not a 
general property of mouse fibroblasts. Furthermore,  addi- 
tion of 10% serum induced reentry of quiescent Swiss 3T3 
into cell cycle (Fig. 1 a), indicating that these cells were 
able to respond mitogenically to an appropriate stimulus. 
Figure 1. Swiss 3T3 cells are resistant to the mitogenic effects of 
v-Src. (a) Swiss 3T3-f29 cells were serum deprived at the restric- 
tive temperature of 40°C (control), and stimulated by addition of 
serum or shift to 35°C for up to 36 h. S-phase ntry was moni- 
tored by thymidine uptake (cpm × 10-4). (Inset) Level of ts LA29 
v-Src expressed in the subclone of Swiss 3T3 used (Swiss f29) and 
is compared with parental Swiss 3T3 cells (control). Immunoblots 
were of lysates from equivalent cell numbers run on the same gel. 
(b) Mitogenesis of NIH 3T3-f29 cells as described for Swiss 3T3- 
f29 in a above. 
Figure 2. AP-1 DNA binding and MAP kinase are not stimulated 
by v-Src in quiescent Swiss 3T3 cells. (a) Gel retardation analysis 
of AP-1 DNA-binding activity in lysates prepared from Swiss 
3T3-f29 cells (upper) and NIH 3T3-f29 cells (lower) that had been 
made quiescent by serum deprivation at 40°C (0) or stimulated by 
serum addition or shift to 35°C for 0.25, 0.5, 1, 2, or 4 h. (b) MAP 
kinase activity immunoprecipitated from lysates of Swiss 3T3-f29 
cells (left) and NIH 3T3-f29 cells (right) that had been made qui- 
escent by serum deprivation at 40°C (0) or stimulated by serum 
addition or shift to 35°C for 1, 2, or 4 h. The substrate used was 
MBP. The lower panel shows the level of p42 MAP kinase deter- 
mined by immunobiotting. MAP kinase activation, quantified by 
scanning laser densitometry of MBP phosphorylated in the in 
vitro MAP kinase assays, is presented as a bar chart. 
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Figure 3. Serum-deprived Swiss 3T3 ceils are resistant to morphological transformation by v-Src. (a) Phase contrast images of Swiss 
3T3-f29 cells that are growing (10% serum, upper) or serum deprived (lower) at 40 or 35°C. (b) Images of serum-deprived NIH 3T3-f29 
cells at 40 or 35°C. 
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AP-1 and MAP Kinase Are Not Activated by v-Src in 
Quiescent Swiss 3T3 Cells 
Since we had previously shown that AP-1 and MAP kinase 
activation are essential components of v-Src-induced mi- 
togenesis, we examined whether these were activated in 
serum-deprived Swiss 3T3-f29 and NIH 3T3-f29 after ad- 
dition of serum or shift to 35°C. Although serum induced 
AP-1 DNA-binding activity, as measured by gel retarda- 
tion of an AP-1 consensus oligonucleotide, shift to the per- 
missive temperature did not appreciably induce AP-1 DNA 
binding in Swiss 3T3 (Fig. 2 a, top). In contrast, activation 
of ts LA29 v-Src by shift to 35°C in NIH 3T3 cells resulted 
in an obvious stimulation of AP-1 DNA binding (Fig. 2 a, 
lower). Similarly, measurement of MAP kinase activity, 
using an immune-complex kinase assay with antiserum 
specific for the carboxy terminus of p42 MAP kinase and 
myelin basic protein (MBP) as substrate, demonstrated 
that shift to permissive temperature sulted in a classical 
early and transient activation in NIH 3T3-f29 (Fig. 2 b, 
right) but induced no response in Swiss 3T3-f29 (Fig. 2 b, 
left). These data show that AP-1 and MAP kinase are 
stimulated upon shift to 35°C in v-Src-responsive quies- 
cent NIH 3T3 cells, but not in the v-Src-unresponsive 
Swiss 3T3 clones. 
v-Src Is Not Translocated to the Cell Periphery in 
Quiescent Swiss 3T3 Cells 
Since the defect in quiescent Swiss 3T3-f29 that renders 
the cells nonpermissive for v-Src-induced mitogenesis was 
apparently upstream of activation of MAP kinase, one 
possibility was that v-Src was not activated or localized 
properly upon shift to 35°C. One prediction of the hypoth- 
esis that the defect is aberrant regulation of v-Src itself is 
that shift of serum-deprived Swiss 3T3-f29 to 35°C would 
also not induce morphological transformation. Thus, we 
compared the cellular morphologies of Swiss 3T3-f29 and 
NIH 3T3-f29 that were either growing or serum deprived 
at the restrictive temperature (40°C) or after shift for 36 h 
to 35°C. As shown, serum-deprived Swiss 3T3-f29 cells 
shifted to 35°C (Fig. 3 a, lower) do not assume the refrac- 
tile rounded morphology characteristic of growing cells 
transformed at 35°C, although they appear granular (Fig. 3 
a, upper). In contrast, serum-deprived NIH 3T3-f29 be- 
come morphologically transformed at 35°C (Fig. 3 b) and 
appear similar to growing cells at this temperature (not 
shown). These observations confirm that the defect in 
v-Src activity in Swiss 3T3 cells is not confined to the mito- 
genic pathways, but that other biological consequences of 
v-Src activity are not induced when these cells are serum 
deprived. This is consistent with aberrant regulation of 
v-Src itself in serum-deprived Swiss 3T3 cells. Further 
characterization of Swiss 3T3-f29 clones showed that ts 
LA29 v-Src was able to induce not only morphological cell 
rounding when the cells were growing but also an en- 
hanced growth rate and growth in soft agar in a tempera- 
ture-dependent manner (data not shown), indicating that 
v-Src was able to function as an efficient oncoprotein in 
Swiss 3T3 cells grown in the presence of serum. 
As mentioned, ts LA29 v-Src is both catalytically acti- 
vated and relocalized from the perinuclear region to the 
cell membrane in response to shift to permissive tempera- 
Figure 4. v-Src from serum-deprived Swiss 3T3-f29 cells is active 
at the permissive temperature. (a) Anti-v-Src immune-complex 
kinase assays using exogenous enolase as substrate, v-Src was im- 
munoprecipitated from lysates of Swiss 3T3-t29 or NIH 3T3-f29 
that had been made quiescent by serum deprivation at 40°C (0), 
or shifted to 35°C for 1, 2, 4, or 7 h. (b) v-Src immunoblots of ly- 
sates used for immune-complex kinase assays. 
ture in rat cells (Welham and Wyke, 1988). Thus, we 
tested the reactivation kinetics of the v-Src tyrosine kinase 
and its subcellular localization. The v-Src kinase from qui- 
escent Swiss 3T3-f29 cells reactivated upon shift to 35°C 
with similar kinetics to v-Src from NIH 3T3-f29 cells, as 
demonstrated by immune-complex kinase assays using ex- 
ogenous enolase as substrate (Fig. 4 a). The level of v-Src 
protein was relatively invariant during temperature-shift 
of both cell lines, indicating that reactivation was due to 
increased specific kinase activity (Fig. 4 b). Furthermore, 
the reactivation kinetics were similar to those for ts LA29 
v-Src from quiescent chicken embryo fibroblasts (CEF/ 
R29), in which this v-Src mutant is an effective mitogen 
and transforming agent (Catling et al., 1993). In addition, 
both quiescent Swiss 3T3-f29 and NIH 3T3-f29 exhibited 
temperature-dependent tyrosine phosphorylation f cellu- 
lar proteins upon activation of v-Sre (not shown), demon- 
strating that activation of the tyrosine kinase occurs in
vivo. 
Examination of the subcellular distribution of v-Src 
showed that temperature-induced translocation to the cell 
periphery was impaired in serum-deprived Swiss 3T3-f29 
(Fig. 5 a). Immunofluorescence confocal microscopy using 
mAb EC10 demonstrated that in growing and serum- 
deprived Swiss 3T3-f29 at 40°C, v-Src was localized around 
the nucleus (Fig. 5 a, 1 and 3). Control cells treated with 
conjugated second antibody alone displayed nuclear fluo- 
rescence that was not seen when primary antibody reac- 
tive with v-Src was also used (not shown). Upon shift to 
35°C, a proportion of the v-Src localized to the cell periph- 
ery in growing cells, predominantly to discrete adhesions 
at early times (Fig. 5 a, 2, upper), and to the membrane/re- 
sidual adhesions at later times in rounded transformed 
cells in which v-Src had induced focal adhesion degrada- 
tion (Fig. 5 a, 2, lower). In contrast, v-Src remained mainly 
in the perinuclear egion in cells, which had been de- 
prived of serum, even after 4 h at the permissive temper- 
ature (Fig. 5 a, 4). At later times (up to 16 h) at 35°C, v-Src 
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Figure 5. (a) Immtmofluorescence confoeal images of cells stained with anti-v-Src and a second antibody conjugated to FITC. 1 and 3 
show growing and serum-deprived Swiss 3T3-f29 cells at 40 °, 2 shows growing Swiss 3T3-f29 cells that had been switched to 35°C for 2 h 
(upper) or 16 h (lower). The arrows point to v-Src present in focal adhesions at early times after transfer to 35°C or at the cell membrane 
and in residual adhesions at a l ter time. 4 shows serum-deprived Swiss 3T3-f29 cells that had been switched to 35°C for 2 h (upper) or 4 
h (lower). (b) v-Src localization i quiescent CEF/R29 and NIH 3T3-f29 at restrictive temperature (41°C for CEF and 40°C for NIH 3T3) 
and after shift to 35°C for 30 rain and 2 h, respectively. Bars, 20 p~m. 
remained perinuclear, although the serum-deprived Swiss 
3T3-f29 cells became granular in appearance, indicating that 
the cells were unhealthy (Fig. 3 a). For  comparison, the 
normal translocation of ts LA29 v-Src to focal adhesions 
induced in CEF/R29 after shift to 35°C for 30 min (Fig. 5 b, 
2) and in quiescent N IH 3T3-f29 after shift to 35°C for 2 h 
(Fig. 5 b, 4) are shown. These observations demonstrate 
that, in contrast o v-Src-responsive c lls, the v-Src in un- 
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Figure 5. 
responsive Swiss 3T3-f29 ceils is not translocated to its site 
of action in focal adhesions at the cell periphery upon shift 
to the permissive temperature. 
Translocation of v-Src Requires an Organized 
Actin Cytoskeleton 
Since Swiss 3T3 are known to differ from other fibroblasts 
by disorganizing the cellular stress fibers and focal adhe- 
sions upon serum deprivation (Ridley and Hall, 1992), we 
examined the cytoskeleton of Swiss 3T3-f29 cells upon se- 
rum deprivation and after serum refeeding. As expected, 
phalloidin staining revealed that in serum-deprived Swiss 
3T3-f29 cells, there were few stress fibers, with much of 
the actin having a punctate distribution (not shown); in 
contrast, stress fibers were detected in quiescent NIH 3T3- 
f29 (not shown). Upon refeeding Swiss 3T3-f29 cells with 
serum, new stress fibers formed rapidly, a process that is 
known to be dependent on the activity of the small G pro- 
tein Rho (Ridley and Hall, 1992). Thus, the loss of orga- 
nized actin stress fibers in quiescent Swiss 3T3 f-29 cells 
correlated with the lack of v-Src translocation to the cell 
periphery. We then tested whether serum-induced refor- 
mation of actin stress fibers restored the ability of ts LA29 
v-Src to translocate to the membrane. Addition f serum 
for 1 h at 35°C resulted in the redistribution of some v-Src 
from around the nucleus outwards to the cell periphery 
(Fig. 6 a). The staining pattern indicated that v-Src was 
present in discrete structures or complexes that appeared 
to align with the newly formed actin stress fibers, shown in 
Fig. 6 b for the same cell. When the eonfocal images from 
staining with anti-v-Src (detected by FITC as green in Fig. 
6 a) and phalloidin (detected by rhodamine as red in Fig. 6 b) 
were overlaid, the colocalization of the v-Src-containing 
complexes with the stress fibers became vident (detected 
as yellow) (Fig. 6 c). This pattern was consistent with the 
idea that v-Src--containing complexes may track along the 
newly formed actin cables to focal adhesions at the stress 
fiber termini. Overlaid images of a group of cells after shift 
to permissive temperature for a longer period in the pres- 
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Figure 6. Reassembly of the organized actin cytoskeleton is permissive for v-Src translocation. Swiss 3T3-f29 ceils, which had been 
made quiescent by serum deprivation at40°C, were refed with 10% serum or microinjected with Val 14-Rho A and shifted to 35°C be- 
fore double staining with anti-v-Src (detected by FITC) and phalloidin (detected by rhodamine), or stained with antivinculin (detected 
by FITC), and visualized by confocal microscopy. (a) v-Src distribution after 1 h of serum at 35°C, (b) actin distribution i the same cell, 
(c) overlaid images showing distribution of both v-Src and actin stress fibers, and (d) overlaid images of a group of cells that had been 
refed with serum at 35°C for 4 h. (e) v-Src distribution after 2 h at 35°C in serum-deprived cells that had been microinjected with Val 14- 
The Journal of Cell Biology, Volume 135, 1996 1558 
Figure 7. Cytochalasin D blocks v-Src translocation and v-Src-induced mitogenesis. (a) Swiss 3T3-f29 cells that had been made quies- 
cent by serum deprivation at 40°C were refed with 10% serum and shifted to 35°C for 4 h in the presence of 0.1 p.g/ml cytochalasin D be- 
fore double staining with phalloidin (detected by rhodamine in 1) and anti-v-Src (detected by FITC in 2). (b) Quiescent NIH 3T3-f29 
cells shifted for 4 h to 35°C in the presence of cytochalasin D were stained as for Swiss 3T3-f29 cells in a. Bars, 20 ixm. 
ence of serum (4 h), showed that much of the v-Src was 
now localized in adhesions at the ends of stress fibers (Fig. 
6 d). The v-Src-containing complexes at these termini 
assumed a more elongated shape, reminiscent of mature 
focal adhesions in Swiss 3T3 cells (Barry and Critchley, 
1994). Microinjection of  an activated form of the small 
G protein Rho A (Val 14-Rho A), which is known to in- 
duce formation of actin stress fibers (Ridley and Hall, 
1992), was able to substitute for serum in permitting trans- 
location of v-Src upon shift to the permissive temperature 
(Fig. 6 e). Control cells that were microinjected with Luci- 
fer yellow dye and shifted to the permissive temperature 
and microinjected cells maintained at the restrictive tem- 
perature did not show localization of v-Src in focal adhe- 
sions (not shown). Although it hasn't been possible for 
double labeling of cells with vinculin and v-Src (since both 
antibodies were raised in mice), we observed that the 
staining pattern of the focal adhesion component vinculin 
was similar to v-Src. 4 h after refeeding quiescent Swiss 
3T3-f29 ceils with serum, vinculin was predominantly 
present in focal adhesions with some punctate staining 
also distributed throughout the cell (Fig. 6 3'). The major 
difference between the vinculin and v-Src distribution 
under these conditions is the retention of a substantial 
amount of v-Src around the nucleus, presumably as a re- 
sult of its vast overexpression. These observations suggest 
that v-Src may be transported along actin stress fibers in 
complexes that are destined to become focal adhesions at 
the stress fiber termini. 
To determine if the serum-induced reformation of actin 
Rho A. Phalloidin staining of the same cells revealed that stress fibers had reformed (not shown). (f) vinculin distribution i  cells after 4 
h of serum at 35°C, treated as for (d). Arrows point out some of the v-Src-containing complexes that have moved out from the perinu- 
clear region. Bars, 20 ixm. 
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stress fibers was a prerequisite for v-Src translocation, we 
provided quiescent Swiss 3T3-f29 cells with serum and 
shifted to the permissive temperature in the presence of 
0.1 Ixg/ml cyotchalasin D, a drug that disrupts the cellular 
actin cytoskeleton and prevents focal adhesion assembly. 
The cytoskeleton was severely disrupted in cytochalasin 
D-treated quiescent Swiss 3T3-f29 cells that had been 
refed with serum and shifted to 35°C for 4 h, as shown by 
the lack of stress fibers (phalloidin staining in Fig. 7 a, 1). 
In addition, v-Src remained tightly located around the nu- 
cleus upon temperature shift (Fig. 7 a, 2), implying that the 
cytoskeleton plays an essential role in the transport of 
v-Src to the cell periphery. Similarly, translocation of v-Src 
is blocked in quiescent NIH 3T3-f29 ceils upon shift to the 
permissive temperature (Fig. 7 b, 2). Consistent with the 
known requirement for v-Src activity at the cell periphery 
for mitogenic activity (Catling et al., 1993), ts LA29 v-Src 
was unable to activate G0/G1- to S-phase progression i cy- 
tochalasin D-treated NIH 3T3-f29 cells upon shift to 35°C 
(not shown). These data indicate that the actin cytoskele- 
ton plays a crucial role in the translocation, and hence the 
biological activity, of v-Src. 
Translocation of v-src to Focal Adhesions Does Not 
Require Organized Microtubules 
The observations described above do not rule out the pos- 
sibility that the activated v-Src--containing complexes are 
associated with structures that align in parallel with the 
Rho-induced actin stress fibers. This, together with the re- 
ported colocalization of c-Src with microtubules (Kaplan 
et al., 1992), prompted us to examine whether the microtu- 
bular network might be involved in the translocation ofv-Src 
to the cell periphery. Anti--a-tubulin staining of Swiss 3T3- 
f29 cells displayed a highly cross-linked array of microtu- 
bules in the cytoplasm, which was distinct from stress fiber 
staining and which was unaffected by serum deprivation 
(Fig. 8 a, for comparison see Figs. 6 b and 8 b). Although 
the staining patterns of ct-tubulin and phalloidin appeared 
distinct, the microtubular and actin networks must cross in 
the cytoplasm and local coalignment may occur. However, 
treatment of serum-deprived Swiss 3T3-f29 cells with 0.5 
ixg/ml of nocodazole, which led to severe disruption of the 
microtubular network (Fig. 8 b), did not block the translo- 
cation of v-Src to focal adhesions (Fig. 8, c and d), indicat- 
ing that the peripheral recruitment of v-Src can occur in- 
dependently of microtubules. 
Recruitment of c-Src to the Cell Periphery also 
Requires the Actin Cytoskeleton 
To determine whether the cytoskeleton was a general me- 
diator of biologically stimulated intracellular transport of 
Src kinases, we tested whether PDGF, a potent fibroblast 
mitogen that is known to require the activity of c-Src or its 
close family members for its effects in NIH 3T3 cells 
(Twamley-Stein et al., 1993), was able to induce transloca- 
tion of c-Src to the cell periphery in a cytoskeleton-depen- 
dent manner. We treated quiescent parental NIH 3T3 cells 
with 5 ng/ml PDGF and examined the subcellular distribu- 
tion of c-Src using mAb N2-17. In unstimulated cells, c-Src 
was distributed throughout the cytoplasm (Fig. 9 a). The 
strong nuclear staining was also seen when the cells were 
incubated with FITC-conjugated second antibody alone 
(data not shown), indicating that it may be nonspecific. In 
PDGF-treated cells, some c-Src translocated tothe cell pe- 
riphery within 30 min (Fig. 9 b), where it remained for 60 
min (Fig. 9 c). In some cells, a staining pattern was ob- 
served that was consistent with stress fiber alignment at 
early times after PDGF treatment (e.g. Fig. 9 b, left). Upon 
double labeling with phalloidin, it was evident hat the pe- 
ripheral regions to which c-Src was recruited coincided 
with regions of dense actin staining (not shown), a prop- 
erty that is associated with structures known as membrane 
ruffles, which are induced by PDGF (Mellstr6m et al., 
1988; Ridley and Hall, 1992). Consistent with a role for the 
actin cytoskeleton i the translocation of c-Src, cytochala- 
sin D blocked PDGF-induced recruitment of c-Src to the 
putative membrane ruffles (Fig. 9 d). 
Discussion 
In order for v-Src to work as an effective oncoprotein, it
must be translocated from its site of synthesis to its site of 
action at the cell periphery. Early efforts to locate v-Src 
within Rous sarcoma virus-infected cells produced appar- 
ently paradoxical views on its subcellular distribution. Bio- 
chemical fractionation, immunofluorescence, and elec- 
tron microscopy suggested that the majority of v-Src in 
transformed cells was associated with the plasma mem- 
brane (Rohrschneider tal., 1979; Willingham et al., 1979; 
Courtneidge t al., 1980). However, there were also re- 
ports that v-Src was concentrated in the perinuclear region 
(Rohrschneider et al., 1979), associated with the cellular 
cytoskeleton (Burr et al., 1980), and located in residual 
focal adhesions (Rohrschneider, 1979; Nigg et al., 1982; 
Kreuger et al., 1984; Kellie et al., 1986). One explanation 
for these seemingly contradictory claims is provided by 
our studies using Swiss 3T3 cells that stably express high 
levels of v-Src protein, but that are resistant to its mitoge- 
nic effects as a result of aberrant membrane localization. 
Immunofluorescence, ombined with the resolving power 
provided by the confocal microscope, has allowed us to 
propose that the actin cytoskeleton plays an important 
role in targeting v-Src, and its cellular homolog c-Src, to 
their sites of action at the cell periphery. 
The ts LA29 mutant v-Src differs from the wild-type 
Figure 8. v-Src transport to focal adhesions i  independent ofmicrotubules. (a) Swiss 3T3-f29 cells that had been made quiescent by se- 
rum deprivation at 40°C were stained with anti-ct-tubulin (detected by FITC) or (b) refed with 10% serum for 1 h at 40°C in the pres- 
ence of 0.5 Ixg/ml nocodazole and triple labeled with phalloidin (detected by rhodamine, left) and v-Src and tubulin (both detected by 
FITC, right). In c and d, cells refed with 10% serum and shifted to 35°C for 1 or 2 h, respectively, in the presence of nocodazole, were 
double stained with anti-v-Src and anti--ct-tubulin (both detected by FITC). White arrows show v-Src at the cell periphery and broken 
white arrows how collapsed microtubular network. That the FITC staining at the cell periphery was due to v-Src was confirmed by sin- 
gle staining of a parallel coverslip. Bars, 20 p~m. 
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Figure 9. PDGF-induced translocation of c-Src to the cell periphery isblocked by cytochalasin D. Parental NIH 3T3 cells were made 
quiescent by serum deprivation (a), treated for 30 or 60 min with 5 ng/ml PDGF (b and c, respectively), or treated with PDGF for 60 min 
in the presence of 0.1 ixg/ml cytochalasin D (d), before staining with mAb N2-17 specific for c-Src (detected by FITC). Arrows point to 
regions of the cell membrane towhich v-Src has been recruited. Bars, 20p~m. 
protein by three amino acid substitutions, one of which is 
responsible for both temperature-sensitive yrosine kinase 
activity and temperature-sensitive localization to the cell 
periphery (Welham and Wyke, 1988). Although the ts 
LA29 v-Src kinase was activated upon shift to permissive 
temperature in unresponsive serum-deprived Swiss 3T3- 
f29 cells, it remained perinuclear and, in this location, the 
kinase activity was not able to induce the downstream sig- 
naling consequences of v-Src as judged by activation of 
MAP kinase and the AP-1 transcription factor. This is con- 
sistent with the properties of a myristylation-defective ver- 
sion of ts LA29 v-Src, which is unable to stimulate AP-1 or 
mitogenesis in CEF (Catling et al., 1993), and demon- 
strates conclusively that translocation to the vicinity of its 
substrates at the cell periphery is an absolute requirement 
for these biological activities. 
A clue to the defect in serum-deprived Swiss 3T3 cells 
that rendered them nonpermissive for activation-depen- 
dent v-Src translocation came from knowledge of the ex- 
treme phenotype that these cells display in disorganizing 
the actin cytoskeleton when they are made quiescent by 
serum-deprivation (Ridley and Hall, 1992; Barry and 
Critchley, 1994). Consistent with this, v-Src was translo- 
cated to the cell periphery in Swiss 3T3 when the cells 
were growing in the presence of serum, conditions that 
restored the actin cytoskeleton and were permissive for 
v-Src-induced growth in suspension, enhanced growth 
rate, and morphological transformation. In addition, v-Src 
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is an effective mitogen and transforming agent in other fi- 
broblast cell lines that maintain some organized cytoskele- 
ton when serum deprived. 
Serum-induced reformation of the actin cytoskeleton, 
which is known to be mediated by the small G protein 
Rho A in Swiss 3T3 cells (Ridley and Hall, 1992), led to 
the rapid redistribution of activated v-Src within the cell. 
At early times after activation, v-Src was present in oval 
shaped 'structures,' which appeared to align along the 
newly formed stress fibers. At later times, more v-Src was 
present in structures that had an elongated shape reminis- 
cent of mature focal adhesions (Barry and Critchley, 1994) 
at the ends of stress fibers. This pattem of localization sug- 
gested that activated v-Src could be recruited into com- 
plexes that were destined to become focal adhesions and 
that these complexes were in turn recruited to the position 
of functional focal adhesions at the ends of stress fibers, 
possibly by tracking along the cytoskeleton. The blocking 
of serum-induced v-Src translocation i Swiss 3T3 cells, 
and in quiescent NIH 3T3 cells, by the actin cytoskeleton- 
disrupting drug cytochalasin D supports a role for the ac- 
tin stress fibers in the translocation of v-Src to the cell pe- 
riphery. Furthermore, the ability of microinjected active 
Rho A to permit v-Src translocation to focal adhesions in- 
dicates a role for the small G protein regulators of the cy- 
toskeleton i  actin-dependent protein trafficking. 
Although little is known about the mechanics of focal 
adhesion assembly and the targeting of components to 
these structures, vinculin staining of Swiss 3T3 cells several 
hours after serum refeeding displayed a similar distribu- 
tion in focal adhesions at the cell periphery with some 
staining in punctate smaller complexes through the cyto- 
plasm. In addition, cytochalasin D-treatment resulted in 
attenuation of vinculin transport to the focal adhesions as 
judged by the perinuclear localization of vinculin under 
these conditions (data not shown). Thus, it is possible that 
active v-Src-containing complexes that move out from the 
perinuclear region in response to serum may represent im- 
mature focal adhesion complexes. If true, this implies that 
the actin stress fibers have an important role in the assem- 
bly and trafficking of complexes containing focal adhesion 
components otheir sites of action at the stress fiber termini. 
In addition to v-Src, we also observed that the cytoskele- 
ton was required for the stimulus-induced translocation of
endogenous c-Src from its cytoplasmic location to the cell 
periphery. In particular, PDGF, a mitogen that requires 
Src family kinase binding to its activated receptor for ac- 
tivity in NIH 3T3 cells (Twamley-Stein etal., 1993), stimu- 
lated redistribution of c-Src to the plasma membrane, spe- 
cifically to regions of dense actin staining around the cell 
periphery. Furthermore, this redistribution was blocked 
by cytochalasin D, demonstrating that c-Src translocation 
to the cell periphery isalso dependent on the actin cytoskel- 
eton. Since PDGF induces dense regions of actin known as 
membrane ruffles in Swiss 3T3 cells (Mellstr/Sm et al., 1988; 
Ridley and Hall, 1992), a process that involves actin rear- 
rangements mediated by the small G protein Rac (Ridley 
et al., 1992), it seems likely that c-Src is being directed to 
membrane ruffles in NIH 3T3 cells by treatment with 
PDGF. These data, together with the requirement for the 
serum-induced, Rho-mediated stress fiber assembly to 
translocate v-Src to focal adhesions, uggest that the exact 
peripheral location of Src kinases may be specified by re- 
arrangements of the actin cytoskeleton under the influ- 
ence of Rho and Rac. 
Although little is known about the mechanism or dy- 
namics of v-Src transport from its site of synthesis to its 
sites of action, molecules that act as binding partners for 
v-Src before its translocation are candidate mediators of 
this process. One such signaling intermediate hat fulfills 
this criteria is the p85/pl10 form of phosphatidylinositol 
(PI) 3-kinase that binds v-Src with kinetics that are indis- 
tinguishable from those of activation of the v-Src tyrosine 
kinase itself in CEF (Haefner et al., 1995). This, together 
with the known role of the yeast homologue of the pl l0 
catalytic subunit of PI 3-kinase, VPS34, in vesicular pro- 
tein trafficking (Schu et al., 1993) and the recently identi- 
fied role of PI 3-kinase in the transport of GLUT 4 glucose 
transporter to the cell membrane (Cheatham et al., 1994; 
Clarke et al., 1994; Kamohara et al., 1995; Kotani et al., 
1995), suggests that PI 3-kinase is a candidate regulator of 
v-Src translocation. I  addition to PI 3-kinase, other possible 
regulators of this process include molecules that interact 
with both v-Src and focal adhesions, uch as focal adhesion 
kinase or paxillin (for review see Schaller and Parsons, 
1994), or v-Src and the cytoskeleton, such as cortactin (Wu 
and Parsons, 1993) or AFAP (for actin filament-associated 
pp60 [Src] substrate; Flynn et al., 1993). The mechanism of 
actin-dependent Src recruitment to the cell periphery and 
the potential role of molecules that interact with Src in this 
process require extensive further experimentation. 
In conclusion, we have identified the actin cytoskeleton 
as an important component of the cellular machinery that 
translocates Src kinase from its site of synthesis to its sites 
of action. Furthermore, our observations, when consid- 
ered with work from Alan Hall's group demonstrating that 
Rho and Rac are crucial regulators of cytoskeletal ssem- 
bly (Ridley and Hall, 1992; Ridley et al., 1992; Nobes and 
Hall, 1995), implicate these small G proteins as potential 
determinants of Src localization mediated by their effects 
on actin organization. Thus, in addition to its more recog- 
nized roles in maintaining cell shape and attachment, in
regulating motility, and in basic cell functions, such as cy- 
tokinesis, we have demonstrated that the actin cytoskele- 
ton is probably also involved in intracellular t ansport pro- 
cesses, as has been suggested (Nobes and Hall, 1995). 
Examples of protein trafficking along actin tracks have 
been described (Fath and Burgess, 1994). More recently, 
cytoskeletal integrity has also been shown to be required 
throughout the growth factor-stimulated Gl-phase of the 
cell cycle in normal cells and to mediate the anchorage- 
dependent expression of cyclin D1 (B6hmer et al., 1996). 
In the case of mitogenesis stimulated by the v-Src onco- 
protein, however, we have shown that induction of G0/G1- 
to S-phase progression requires the cytoskeleton for local- 
ization at the cell periphery necessary for initiating the mi- 
togenic ascade. Thereafter, v-Src-induced cell cycle pro- 
gression proceeds independently of cytoskeletal integrity 
since v-Src activity induces rapid cytoskeletal disorganiza- 
tion (within 1-2 h in CEF) and subsequent transit of Gv 
Details of the mechanism by which v-Src and other onco- 
proteins that can induce anchorage-independent growth 
overcome the normal cytoskeletal-dependent checkpoint 
in G1 remain to be established. 
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